oxazepam has been researched along with Cognition Disorders in 8 studies
Oxazepam: A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia.
oxazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a hydroxy group at position 3 and phenyl group at position 5.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Kava was found to have no negative effect on cognition, whereas a reduction in alertness (p < 0." | 6.77 | The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study. ( Bousman, C; Laporte, E; Murray, G; Ng, C; Sarris, J; Scholey, A; Schweitzer, I; Stough, C, 2012) |
| "Kava was found to have no negative effect on cognition, whereas a reduction in alertness (p < 0." | 2.77 | The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study. ( Bousman, C; Laporte, E; Murray, G; Ng, C; Sarris, J; Scholey, A; Schweitzer, I; Stough, C, 2012) |
| " Group B patients (20) were treated by tapering of oxazepam dosage (from 120 mg) and with saline solution (as placebo) instead of FLU for 8 days." | 2.70 | Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study. ( Brewer, C; Gerra, G; Giusti, F; Moi, G; Zaimovic, A, 2002) |
| "A 55 year old man developed an acute confusional state with grossly impaired short-term memory accompanied by a Status Petit Mal epilepsy pattern on EEG, one to two weeks after abruptly discontinuing a large amount of oxazepam and a smaller amount of alcohol." | 1.27 | Acute confusional state with status petit mal as a withdrawal syndrome--and five year follow-up. ( Billings, RF; Hersch, EL, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gogol, M | 1 |
| Hartmann, H | 1 |
| Wustmann, S | 1 |
| Simm, A | 1 |
| Sarris, J | 1 |
| Scholey, A | 1 |
| Schweitzer, I | 1 |
| Bousman, C | 1 |
| Laporte, E | 1 |
| Ng, C | 1 |
| Murray, G | 1 |
| Stough, C | 1 |
| Gerra, G | 1 |
| Zaimovic, A | 1 |
| Giusti, F | 1 |
| Moi, G | 1 |
| Brewer, C | 1 |
| Cotroneo, A | 1 |
| Gareri, P | 1 |
| Nicoletti, N | 1 |
| Lacava, R | 1 |
| Grassone, D | 1 |
| Maina, E | 1 |
| De Sarro, G | 1 |
| Cabodi, S | 1 |
| Puustinen, J | 1 |
| Nurminen, J | 1 |
| Kukola, M | 1 |
| Vahlberg, T | 1 |
| Laine, K | 1 |
| Kivelä, SL | 1 |
| Buffett-Jerrott, SE | 2 |
| Stewart, SH | 2 |
| Teehan, MD | 2 |
| Bird, S | 1 |
| Hersch, EL | 1 |
| Billings, RF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Development of a Coordinated, Community-Based Medication Management Model for Home-Dwelling Aged in Primary Care[NCT02545257] | 191 participants (Actual) | Interventional | 2015-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for oxazepam and Cognition Disorders
| Article | Year |
|---|---|
The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety; Cognition Disorders; Cross-Over Studies; Doub | 2012 |
Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study.
Topics: Adult; Anti-Anxiety Agents; Antidotes; Benzodiazepines; Blood Pressure; Cognition Disorders; Diagnos | 2002 |
Associations between use of benzodiazepines or related drugs and health, physical abilities and cognitive function: a non-randomised clinical study in the elderly.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Azabicyclo Compounds; Benzodiazepines; Cognitio | 2007 |
A further examination of the time-dependent effects of oxazepam and lorazepam on implicit and explicit memory.
Topics: Adult; Analysis of Variance; Attention; Cognition Disorders; Conscious Sedation; Cues; Double-Blind | 1998 |
An examination of differences in the time course of oxazepam's effects on implicit vs explicit memory.
Topics: Adolescent; Adult; Age Factors; Analysis of Variance; Anti-Anxiety Agents; Attention; Cognition; Cog | 1998 |
3 other studies available for oxazepam and Cognition Disorders
| Article | Year |
|---|---|
Influence of central nervous system-acting drugs on results of cognitive testing in geriatric inpatients.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Antidepressive Agents; Benzodiazepines; Central Nervous | 2014 |
Effectiveness and safety of hypnotic drugs in the treatment of insomnia in over 70-year old people.
Topics: Aged; Cognition Disorders; Dementia; Depression; Drug Administration Schedule; Female; Health Status | 2007 |
Acute confusional state with status petit mal as a withdrawal syndrome--and five year follow-up.
Topics: Acute Disease; Cognition Disorders; Confusion; Diazepam; Follow-Up Studies; Humans; Injections, Intr | 1988 |